RxDoctor Payments Data

Anna Ledford

Internal Medicine · Valdosta, GANPI 1154671063

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $86,100 of the $108,095 with a category attached, or 79.7%. Lilly USA, LLC accounts for 98.9% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $81,428, more than ten times the $14 reported in 2020. Among internal medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$108,095in general payments, 2019–2025

Across 431 payments — averaging $250.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$107K
  • AbbVie$505
  • Dexcom, Inc.$160
  • Amgen$108
  • Gilead$56
  • Bayer$47
  • plus $268 from 11 others

What the payments were for

  • Speaking & faculty fees$86,10080%
  • Travel & lodging$18,29917%
  • Food & beverage$3,6963%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$108,095 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia

Other internal medicine in Valdosta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →